Dr Rowan Miller is a Medical Oncologist specialising in gynaeoncology and early phase clinical trials at University College London and St Bartholomew’s Hospitals London, UK. Her research interests include novel therapies for gynaecological cancer and utilising genomics and biomarkers to guide therapy in patients, particularly in early-phase clinical trials.
She was awarded a Cancer Research UK Fellowship and attained a PhD from the Institute of Cancer Research, University of London. During her PhD she won a Merit award for her research from the American Society of Clinical Oncology (ASCO) and the Royal Society of Medicine.
She has published research articles on novel therapeutic targets for ovarian clear cell cancers and presented at international conferences.
She completed a fellowship at Dana Farber Cancer Institute, Harvard University working in germ cell cancers and continues to maintain research links with this group.
She is involved in a number of clinical and basic science research projects across two academic centres and is the co-chief investigator for the PEACOCC Study.